(Q45087228)

9 December 2017

title

Plasmapheresis in treatment of human T-lymphotropic virus type-I associated myelopathy (English)

1 reference

Human T-lymphotropic virus 1

9 December 2017

main subject

0 references

author name string

H Matsuo

1

1 reference

9 December 2017

T Nakamura

2

1 reference

9 December 2017

M Tsujihata

3

1 reference

9 December 2017

I Kinoshita

4

1 reference

9 December 2017

A Satoh

5

1 reference

9 December 2017

I Tomita

6

1 reference

9 December 2017

S Shirabe

7

1 reference

9 December 2017

K Shibayama

8

1 reference

9 December 2017

S Nagataki

9

1 reference

9 December 2017

language of work or name

English

0 references

publication date

1 November 1988

1 reference

9 December 2017

1 reference

9 December 2017

volume

2

1 reference

9 December 2017

issue

8620

1 reference

9 December 2017

page(s)

1109-1113

1 reference

HTLV-I associated myelopathy, a new clinical entity.

9 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2888%2990525-9

7 January 2021

Chronic progressive myelopathy associated with elevated antibodies to human T-lymphotropic virus type I and adult T-cell leukemialike cells

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2888%2990525-9

7 January 2021

Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2888%2990525-9

7 January 2021

Endemic tropical spastic paraparesis associated with human T-lymphotropic virus type I: a clinical and seroepidemiological study of 25 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2888%2990525-9

7 January 2021

Human T-lymphotropic virus type I antibodies in the serum of patients with tropical spastic paraparesis in the Seychelles

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2888%2990525-9

7 January 2021

HTLV-I and tropical spastic paraparesis.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2888%2990525-9

7 January 2021

Myelopathies and retroviral infections

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2888%2990525-9

7 January 2021

Retrovirus-associated myelopathies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2888%2990525-9

7 January 2021

Immunosuppression and plasma-exchange in the treatment of Goodpasture's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2888%2990525-9

7 January 2021

Plasmapheresis in the management of acute systemic lupus erythematosus?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2888%2990525-9

7 January 2021

Plasma exchange in SLE

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2888%2990525-9

7 January 2021

Plasmapheresis and immunosuppressive drug therapy in myasthenia gravis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2888%2990525-9

7 January 2021

Plasmapheresis in multiple sclerosis: preliminary findings

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2888%2990525-9

7 January 2021

Plasmapheresis in multiple sclerosis: preliminary study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2888%2990525-9

7 January 2021

Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2888%2990525-9

7 January 2021

Plasmapheresis decreases neuroelectric blocking activity in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2888%2990525-9

7 January 2021

10.1016/S0140-6736(88)90525-9

Identifiers

DOI

1 reference

9 December 2017

1 reference